• Restructuring: The Company will undertake an internal restructuring of its consumer business by consolidating the relevant assets, comprising its Australian and Hong Kong subsidiaries, its compounding product portfolio of approximately 40 WaferiX-based formulations, and the proposed WaferiX direct-to-consumer ("DTC") telehealth platform currently under development, under a newly incorporated holding company to be known as Ligo Pharma Pte Ltd ("Ligo").

• Entity Focus: Following the internal restructuring, iX will own 100% of Ligo and Ligo will operate as the dedicated vehicle for iX's US market strategy, holding the consumer-facing assets and the commercial licence to iX's sublingual delivery technology.

• Market Entry: iX can enter the large and growing US longevity and lifestyle health market immediately, without waiting for FDA approval.

• Commercial Pathway: The US 503A/B compounding framework allows iX to commercialise approximately 40 WaferiX-based formulations now, through a pathway that does not exist in any other market iX currently operates in.

• Strategic Objective: The strategic objective is to build WaferiX DTC, a direct-to-consumer telehealth business, not merely a compounding operation.

• Peptide Opportunity: iX has the technology capable of delivering peptides sublingually, without injection, and several peptides in iX's own pipeline are among those under active regulatory review.

• Operational Necessity: US-based manufacturing is operationally necessary to execute this strategy. US-based manufacturing eliminates constraints such as tariff exposure and supply chain uncertainties.

• Corporate Flexibility: Ligo creates a focused, investable entity that can be understood and valued independently of iX's pharmaceutical assets, and preserves flexibility for corporate actions including a spin-off listing on SGX-ST or NASDAQ.

• Joint Venture: iX and GLD are in advanced discussions on the terms of a proposed joint venture that would incorporate Orion into the Ligo structure, with GLD becoming a co-shareholder of Ligo.

See link for full media release: https://lnkd.in/gYR3F93Y